Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2 (SPR1NT)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03505099 |
|
Recruitment Status :
Active, not recruiting
First Posted : April 23, 2018
Last Update Posted : January 7, 2020
|
Sponsor:
AveXis, Inc.
Collaborator:
PRA Health Sciences
Information provided by (Responsible Party):
AveXis, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | October 2020 |
| Estimated Study Completion Date : | June 2023 |